India has crossed a significant milestone in its healthcare journey, with organ donation pledges surpassing the 5 lakh mark.
A new Roche treatment combination has moved a step closer to the market after the US Food and Drug Administration (FDA) accepted the company’s supplemental Biologics License Application (sBLA).
India's Ebola support to African nations during the ongoing Ebola outbreak has brought renewed attention to a long-standing challenge facing the continent—its limited ability to produce vaccines locally.
The 6th Drug Safety Symposium 2026 - India Chapter, scheduled for June 24th & 25th, 2026 in Mumbai, will bring together leading voices from across the pharmacovigilance ecosystem to address one of the industry’s most pressing questions
The Shigella threat in Kerala continues to grow as the state reported one more death linked to the infection along with seven fresh cases from multiple districts.
Himachal Pradesh invests Rs 150 crore in diagnostics as the state government moves to strengthen healthcare infrastructure across the state.
Aurobindo Pharma has moved a step closer to completing its USD 250 million acquisition of Lannett Company after receiving approval from the US Federal Trade Commission (FTC).
Sun Pharma’s latest acquisition marks another strategic step in its efforts to strengthen its presence beyond traditional pharmaceuticals.
Sun Pharma recall has once again brought attention to drug manufacturing standards and regulatory compliance in the United States.
.jpeg "Are Generic Cancer Drugs Driving India Pharma Growth?")
India’s generic cancer drug market is expanding with improved affordability, innovation, and access, as companies like Alembic advance complex oncology generics globally.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")